Filing Details
- Accession Number:
- 0001209191-17-016813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-02 17:30:20
- Reporting Period:
- 2017-02-28
- Filing Date:
- 2017-03-02
- Accepted Time:
- 2017-03-02 17:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180262 | Herbalife Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1343530 | John Tartol | 800 W. Olympic Boulevard, #406 Los Angeles CA 90015 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-28 | 13,064 | $22.94 | 201,486 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-28 | 5,306 | $56.49 | 196,180 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2017-03-02 | 2,758 | $56.48 | 193,422 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2017-02-28 | 13,064 | $0.00 | 13,064 | $22.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-04-15 | 2017-05-07 | No | 4 | M | Direct |
Footnotes
- The reporting person received 7,758 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,306 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on February 28, 2017 of $56.49 and sold 2,758 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise.
Billionaire Hedge Funds
